Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology.
| FactSnippet No. 1,657,648 |
In 2016, Allergan sold its generic business, Actavis, to Teva Pharmaceuticals for $40.
| FactSnippet No. 1,657,649 |
Allergan plc was created from the 2015 merger and Irish corporate tax inversion of two companies, Irish-based Actavis plc and US -based Allergan, Inc.
| FactSnippet No. 1,657,650 |
In 1977, Allergan announced plans to build a factory in Westport, Ireland.
| FactSnippet No. 1,657,651 |
In 1989, Allergan opened a manufacturing plant in Waco, Texas to manufacture eye care products.
| FactSnippet No. 1,657,652 |
In 1991, Allergan acquired the company Oculinum which manufactured products for eye muscle disorders.
| FactSnippet No. 1,657,653 |
In 1996, Allergan received FDA approval for Alphagan ophthalmic solution for open-angle glaucoma and ocular hypertension.
| FactSnippet No. 1,657,654 |
In 1998, Allergan established The Allergan Foundation, a private US-based charitable foundation.
| FactSnippet No. 1,657,655 |
In 2005, Allergan acquired Inamed which had a licensing agreement with Corneal Group Laboratoires for Juvederm products.
| FactSnippet No. 1,657,656 |
In September 2018, Allergan acquired the aesthetic company, Bonti, for $195 million.
| FactSnippet No. 1,657,657 |